BioCorRx President Brady Granier takes paid leave; CEO Lourdes Felix assumes duties

BioCorRx Inc.

President Brady Granier granted paid administrative leave from Oct 30, 2023 to Jan 30, 2024; remains on board.
CEO/CFO Lourdes Felix assumes Granier's responsibilities effective Oct 30; compensation unchanged.
Leave period spans three months; no other officer changes disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Brady Granier

President

BICX · BioCorRx Inc.

Effective: 2023-10-30
Filed: November 2, 2023, 7:59 PM ET

On October 30, 2023, the board of directors (the “Board”) of BioCorRx Inc. (the “Company”) approved Brady Granier’s request for a paid administrative leave of absence from his position as the President of the Company for the period between October 30, 2023 and January 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brady Granier changed role as President at BioCorRx Inc..

Action: granted paid administrative leave of absence
Role: President

Exact text from the filing

On October 30, 2023, the board of directors (the “Board”) of BioCorRx Inc. (the “Company”) approved Brady Granier’s request for a paid administrative leave of absence from his position as the President of the Company for the period between October 30, 2023 and January 30, 2024.

View on SEC.gov

BioCorRx Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-008060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.